REKLAMA
GPW

SOPHARMA AD: Notification from "Donev Investments Holding" AD in accordance with Regulation 596/2014 for transactions with shares of "Sopharma" AD

2025-06-13 11:34
publikacja
2025-06-13 11:34
Spis treści:

1. REPORT

2. INFORMATION ABOUT THE ENTITY

3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY


Spis załączników:
Donev_investments_holding_Sopharma_EN_2025.06.12Buy.pdf  (REPORT)

POLISH FINANCIAL SUPERVISION AUTHORITY
UNI - EN REPORT No 46 / 2025
Date of issue: 2025-06-13
Short name of the issuer
SOPHARMA AD
Subject
Notification from "Donev Investments Holding" AD in accordance with Regulation 596/2014 for transactions with shares of "Sopharma" AD
Official market - legal basis
art. 56. 1. 2 of Act on Public Offering.
Unofficial market - legal basis
Contents of the report:
Notification from "Donev Investments Holding" AD in accordance with Regulation 596/2014 for transactions with shares of "Sopharma" AD
Annexes
File Description
Donev investments holding_Sopharma_EN_2025.06.12Buy.pdfDonev investments holding_Sopharma_EN_2025.06.12Buy.pdf Notification from "Donev Investments Holding" AD in accordance with Regulation 596/2014 for transactions with shares of "Sopharma" AD

SOPHARMA AD
(fullname of the issuer)
SOPHARMA AD Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
1220 Sofia
(post code) (city)
IlienskoShosse 16
(street) (number)
+359 2 813 42 00 +359 2 936 02 86
(phone number) (fax)
(e-mail) (web site)
nd
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2025-06-13 Ognian Donev Executive Director
Źródło:Komunikaty spółek (ESPI)
Tematy
Najlepsze konta premium – wrzesień 2025 r.
Najlepsze konta premium – wrzesień 2025 r.
Advertisement

Komentarze (0)

dodaj komentarz

Polecane

Najnowsze

Popularne

Ważne linki